ACTO and ScienceMedia: A New Dawn for Life Sciences Training
In a significant move within the life sciences sector,
ACTO and
ScienceMedia have joined forces to enhance the training and confidence of field teams. This collaboration is set to change the landscape of clinical competency, ensuring that sales, marketing, and medical teams are equipped with the best possible resources to engage healthcare providers effectively.
ACTO, renowned for its AI-powered Intelligent Field Excellence (IFE) platform, focuses on optimizing engagement in the life sciences through technology. Meanwhile, ScienceMedia is a pioneer in providing scientifically validated clinical training, boasting a library of over 400 continuously updated courses covering various disease states and therapeutic areas.
Empowering Field Teams with AI Technology
Under the new partnership, ScienceMedia's comprehensive training resources will be seamlessly integrated into ACTO's marketplace. This integration means that field teams will have immediate access to a wealth of information that is not only comprehensive but also tailored for real-world applications. This partnership aims to ensure that healthcare professionals (HCPs) receive well-informed interactions, ultimately leading to better health outcomes for patients.
Parth Khanna, CEO of ACTO, expressed his enthusiasm about this collaboration: "By integrating ACTO's AI-driven engagement platform with the rich, evidence-based medical training of SMi Source, we are equipping field teams with instant access to the insights, tools, and support they need to become true 'Masters of the Message.'" This statement underscores the commitment both companies have in delivering exceptional tools to empower their users.
Enhancing HCP Interactions
The integration of ScienceMedia's SMi Source training with ACTO's engagement tools equips life sciences teams with the necessary competency to handle various scenarios in the field. With instant access to brand-approved content and messaging, field professionals can manage brand narrative proficiently and assess their interaction impact accurately. This aligns well with the increasing demand for accountability and compliance in the life sciences industry, ensuring every engagement meets regulatory standards.
ScienceMedia's CEO, Malachi Bierstein, emphasized the synergy between the two companies' missions. He noted, "ACTO's innovative approach to engagement aligns perfectly with our goal to enhance clinical competency across the life sciences industry." This collective vision is crucial as the industry faces more scrutiny and demand for high-quality training and interaction standards.
The Future of Life Sciences Training
With the partnership now in effect, both ACTO and ScienceMedia are poised to lead the charge in revolutionizing clinical training. This collaboration enables life sciences field professionals to approach their roles with increased confidence and clinical expertise, allowing them to engage HCPs more effectively.
As the healthcare landscape continues to evolve with new technologies and methodologies, this partnership between ACTO and ScienceMedia is timely and essential. Companies looking to elevate their training programs and improve field team interactions should take advantage of this opportunity.
For more information about this innovative partnership and its implications for life sciences training, connect with ACTO or ScienceMedia directly and explore how these tools can enhance your team's capabilities.
About ACTO
ACTO leverages AI technology to offer an IFE platform designed specifically for the life sciences industry. This platform strives to improve customer engagement and boost brand performance, enabling field professionals to communicate effectively with HCPs.
About ScienceMedia
ScienceMedia is transforming clinical trial efficiency and is at the forefront of training innovation, providing solutions that enhance therapeutic area knowledge and streamline trial processes. Through their comprehensive training resources, they are set to save both time and costs in clinical research endeavors.